Medical Innovation

UN talks on R&D system 'leave the greater part of the job undone'

(c) TaunusGrafik

‘Concrete proposals to ensure urgently needed drugs and diagnostics are developed for developing country diseases have not received support.  Considering the colossal needs we see in MSF daily practice, this is a lost opportunity,’ said Dr. Tido von Schoen-Angerer, Director of Médecins Sans Frontières (MSF)’s Access Campaign at the close of UN health R&D summit.

Read the full statement

Read the MSF press release (Monday 28th April)

Read more about the IGWG and what it can do

Latest Updates from the MSF team at the IGWG

Thursday 1 May Read MSF's statement to the IGWG

Read Monday's update as the negotiations kick off

Read MSF's earlier submissions to the IGWG

Read MSF's report on progress at the IGWG

Read MSF's Comments to the European Commission on the WHO draft Global Strategy and Plan of Action on public health, innovation and IP

 

 

Put Patients First

(c) Donald Weber

Under discussion at the IGWG negotiations are a variety of proposals to stimulate both better access to existing drugs and steer research and development agendas towards the greatest medical needs. Click here to read more about them

Is the GAVI plan for pneumococcal vaccine too expensive ?

© Elisabeth Lipsewers

The pneumococcal vaccine could save millions of lives. But the Advance Market Commitment, set up by GAVI to fund it, is far too expensive.

Read the Campaign's director, Dr. Tido von Schoen-Angerer, in Development Today.

 

Introduction to Medical Innovation